We are definitely in their radar. But we have th
Post# of 155285

We touch on this in COVID as well as other indications. We have to provide them with irrefutable data. Once we have an approved drug, other indications become easier.
Had we obtained approval in HIV prior to COVID, I believe this would have move much quicker.

